Aliment Pharmacol Ther

1. KOPPELMAN LJM, Loveikyte R, van der Meulen-de Jong AE
   Letter: External Validation of Hepcidin Thresholds for Predicting Response to Iron Therapy in Active Inflammatory Bowel Disease. Authors' Reply.
   Aliment Pharmacol Ther. 2026 Aug 26. doi: 10.1111/apt.70927.
   

   >> Share

   
   
2. MURAMOTO Y, Kuwada T, Shiokawa M
   Editorial: Anti-Integrin alphavbeta6 Autoantibodies for Distinguishing Ulcerative Colitis From Crohn's Disease.
   Aliment Pharmacol Ther. 2026 Aug 23. doi: 10.1111/apt.70947.
   

   >> Share

   
   
3. SAWARD G, Heerasing N
   Letter: Acute Severe Ulcerative Colitis in the Advanced Therapy Era: Is Lowering the CRP Threshold Enough?
   Aliment Pharmacol Ther. 2026 Aug 23. doi: 10.1111/apt.70943.
   

   >> Share

   
   

   
   Am J Gastroenterol

4. CONTIJOCH E, Moses J
   Early Use of Anti-Tumor Necrosis Factor Therapy for Penetrating Complications in Children With Crohn's Disease: Multicenter Insight to a Challenging Clinical Problem.
   Am J Gastroenterol. 2026 Aug 27. doi: 10.14309/ajg.0000000000004154.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

5. RIBALDONE DG, Tribocco E, Scaldaferri F, Murgiano M, et al
   Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.
   Clin Gastroenterol Hepatol. 2026 Aug 27:S1542-3565(26)00637.
   

   >> Share

   
   
6. FORSS A, Axelrad J, Soderling J, Marild K, et al
   Serious infections in patients with inflammatory bowel disease and corticosteroids: A propensity score-matched study.
   Clin Gastroenterol Hepatol. 2026 Aug 28:S1542-3565(26)00642.
   

   >> Share

   
   

   
   Dig Dis Sci

7. MIKHAIL I, Odah T, Hashash JG, Farraye J, et al
   Association Between Inflammatory Bowel Disease in Women and the Fertility Marker Anti-Mullerian Hormone.
   Dig Dis Sci. 2026 Aug 21. doi: 10.1007/s10620-026-10191.
   

   >> Share

   
   
8. HU X, Chen J, Zhou Y, Ji X, et al
   n-3 Polyunsaturated Fatty Acids Improve DSS-Induced Acute Colitis in Mice via Intestinal Barrier Fortification and Gut Microbiome Modulation.
   Dig Dis Sci. 2026;71:4252-4269.
   

   >> Share

   
   
9. CLARKE K, Pelton M, Barnes EL, Liu JJ, et al
   IBD Care Across Diverse Patient Populations: Changing the Narrative.
   Dig Dis Sci. 2026;71:3844-3849.
   

   >> Share

   
   
10. MAYER L, Frech M, Ekowa N, Boone DL, et al
    A Proposed Standardized Scoring Equation for Murine Models of Colitis.
    Dig Dis Sci. 2026;71:3448-3457.
    

    >> Share

    
    
11. WANG J, Luo A, Yao Y, Liu A, et al
    cGAS-STING Modulates the NF-kappaB Pathway to Influence the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.
    Dig Dis Sci. 2026 Aug 24. doi: 10.1007/s10620-026-10183.
    

    >> Share

    
    
12. MOGHE R, Klein J, Choden T
    Holding the Line: Navigating Upadacitinib-Induced Neutropenia in Refractory Ulcerative Colitis.
    Dig Dis Sci. 2026 Aug 25. doi: 10.1007/s10620-026-10176.
    

    >> Share

    
    

    
    Eur J Gastroenterol Hepatol

13. KARIM A, Alam T, Masood M, Kumari K, et al
    Beyond tissue drug concentrations: additional considerations in anti-tumor necrosis factor penetration among patients with perianal fistulizing Crohn's disease.
    Eur J Gastroenterol Hepatol. 2026;38:1239.
    

    >> Share

    
    

    
    Gut

14. CHEN R, Kim HJ, Bushra M, Phi Dang C, et al
    Childhood exposure to a sibling with Crohn's disease alters gut microbiome and Crohn's disease susceptibility.
    Gut. 2026 Aug 25:gutjnl-2026-339257. doi: 10.1136/gutjnl-2026-339257.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

15. SHAHUB S, Lin KC, Choi NK, Garcia NM, et al
    Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease.
    Inflamm Bowel Dis. 2026 Aug 28:izag173. doi: 10.1093.
    

    >> Share

    
    
16. QURAISHI MN, Jairath V, Al-Bawardy B
    Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.
    Inflamm Bowel Dis. 2026 Aug 27:izag172. doi: 10.1093.
    

    >> Share

    
    
17. DIAZ-DIAZ LM, Estremera-Rodriguez L, Rojas-Correa M, Quintana MDC, et al
    Diet quality, gut microbiome, and inflammatory signatures in Puerto Rican adults with Crohn disease: a multidimensional analysis.
    Inflamm Bowel Dis. 2026 Aug 26:izag161. doi: 10.1093.
    

    >> Share

    
    

    
    J Crohns Colitis

18. GUO A, Sigvardsson I, Imberg H, Lerchova T, et al
    Modifiable lifestyle factors in early life and inflammatory bowel disease risk in two birth cohorts.
    J Crohns Colitis. 2026;20:jjag114.
    

    >> Share

    
    
19. FRASCATANI R, Serra MA, Iannucci A, Colella M, et al
    BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype.
    J Crohns Colitis. 2026;20:jjag128.
    

    >> Share

    
    
20. KENNEDY JM, De Silva AN, Morales PS, Poveda Turrado CG, et al
    2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial.
    J Crohns Colitis. 2026;20:jjag120.
    

    >> Share

    
    

    
    Scand J Gastroenterol

21. BORKOVSKY T, Cohen NA, Shoam O, Bannon L, et al
    Factors associated with mesalamine refractory ulcerative proctitis requiring advanced medical treatments.
    Scand J Gastroenterol. 2026;61:956-963.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share